CAJ | 학술논문

从澳大利亚药品管理机构、药品管理政策、药品福利计划3个方面,对澳大利亚的药品管理体制进行了深入的分析,总结了澳大利亚药品管理方面的经验,认为澳大利亚政府医药卫生系统建立了顺畅明确的补偿机制,药品定价方法灵活并能兼顾多方利益,决策中注重依托技术力量,对特殊人群采取特殊照顾政策,最大限度地满足了患者用药需求,这些做法值得国内借鉴.
종오대리아약품관리궤구、약품관리정책、약품복리계화3개방면,대오대리아적약품관리체제진행료심입적분석,총결료오대리아약품관리방면적경험,인위오대리아정부의약위생계통건립료순창명학적보상궤제,약품정개방법령활병능겸고다방이익,결책중주중의탁기술역량,대특수인군채취특수조고정책,최대한도지만족료환자용약수구,저사주법치득국내차감.
This article made an in-depth analysis of the pharmaceutical system of Australia in terms of its drug regulatory authorities,drug management policies and drug benefit plans.A summary of the Australian experiences hold that health system of the Australian government boasts a smooth and clear compensation mechanism,and flexible and a drag pricing approach ensuring interests of all parties.Its decision-making emphasizes technical support and covers specific groups of people with special policies,meeting patients' drug needs to the maximum.All these practices are worthy of learning for China.